Bionxt Solutions
  • About Us
    • About Us
    • Our Team
  • Our Products
    • Point-of-Care Diagnostics
    • Drug Delivery
    • Psychedelics
  • News
  • Investors
    • Investor Information
    • Shareholder Documents
  • Contact
  • Home

Our News & Updates

Page: 2

Show All Press Releases Diagnostics Psychedelics Drug Delivery

Press Releases, Psychedelics

XPhyto provides progress update on Psychedelic Medicine Programs and Novel Compounds Milestone

Feb 22, 2022

Vancouver, Canada, and Uttenweiler, Germany (February 22, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...

Continue Reading

Press Releases

XPhyto Reports on its Three Primary Business Divisions

Feb 8, 2022

Vancouver, Canada, and Uttenweiler, Germany (February 8, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report...

Continue Reading

Diagnostics, Press Releases

XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as part of Multi-Product Rollout Strategy

Feb 1, 2022

Vancouver, Canada, and Uttenweiler, Germany (February 1, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Press Releases

XPhyto Provides Update on Integration of 3a-diagnostics GmbH

Jan 24, 2022

Vancouver, Canada, and Uttenweiler, Germany (January 24, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...

Continue Reading

Press Releases

XPhyto Announces Head of Sales, Europe

Jan 17, 2022

Vancouver, Canada, and Uttenweiler, Germany (January 17, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Diagnostics, Press Releases

XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia

Jan 13, 2022

Vancouver, Canada, and Uttenweiler, Germany (January 13, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Press Releases

XPhyto Announces New Director of Business Development and Head of Diagnostic Research

Jan 10, 2022

Vancouver, Canada, and Uttenweiler, Germany (January 10, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Drug Delivery, Press Releases

XPhyto Epilepsy clinical trial planned in 2022 with its proprietary fast-dissolving CBD oral strips

Dec 15, 2021

Vancouver, Canada, and Uttenweiler, Germany (December 15, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...

Continue Reading

Press Releases

XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH

Dec 6, 2021

The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technologyThe acquisition of 3a, a German-based rapid point-of-care...

Continue Reading

Press Releases

XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000

Nov 29, 2021

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC – November 26, 2021 ‐ XPhyto Therapeutics Corp. (“XPhyto”...

Continue Reading

Press Releases

XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development

Nov 3, 2021

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, and Uttenweiler, Germany (November 3, 2021) -...

Continue Reading

Drug Delivery, Press Releases

XPhyto Reports Development Update for its Drug Delivery Business

Oct 12, 2021

Rotigotine transdermal skin patch optimization and pivotal study planning underwayRotigotine patch manufacturing, sales and marketing in preparationCannabinoid oral dissolvable film (ODF) programs advanced, CBD ODF...

Continue Reading
Page 2 of 8‹12345›››
Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.

  • About Bionxt
  • Our Team
  • Our Products
  • Careers
  • Investor Information
  • Company/Investor Presentation
  • Press Releases
  • Request Info
  • Legal Information
  • Cautionary Note
  • Privacy Policy
  • Contact
Xphyto test tubes in laboratory footer
Copyright © 2023 Bionxt Solutions
This website uses cookies and third party services. By clicking “Accept”, you consent to the use of all cookies
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT